March 2025 – The VASA Project and leading global health stakeholders convened at the Schistosomiasis Stakeholder Meeting in Bangkok, Thailand, on January 15-16, 2025, to accelerate the development of a first-ever schistosomiasis vaccine. With millions affected annually by this neglected tropical …
News
VASA Project Achieves Major Milestone: Completion of Phase 1b Enrollment for Schistosomiasis Vaccine Trial
Advancing the Fight Against Schistosomiasis with Rigorous Clinical Research October 2024 – The VASA Project has reached a critical milestone in the development of its schistosomiasis vaccine, successfully completing enrollment for the Phase 1b clinical trial in Madagascar (MIVR) and Burkina Faso …
Momentum is building in the Vaccines Against Schistosomiasis for Africa project (VASA)
On August 18 2023, the kickoff investigator meeting for a crucial Phase 1b clinical trial for the Schistoshield® schistosomiasis vaccine took place in the Madagascar Institute for Vaccine Research (MIVR), with partners from the Groupe de Recherche Action …
Momentum is building in the Vaccines Against Schistosomiasis for Africa project (VASA)Read More
Release of new WHO guidelines on control and elimination of human schistosomiasis
WHO provides a new guideline on control and elimination of human schistosomiasis. The goal of this guideline is to provide evidence-based recommendations to countries in their efforts to accomplish schistosomiasis morbidity control and elimination as a public health problem, and to move towards …
Release of new WHO guidelines on control and elimination of human schistosomiasisRead More
News of SchistoShield Phase 1a study initiation
Participant in Kaiser Permanente Washington Health Research Institute (KPWHRI) trial, based in Seattle, received the first injection of the SchistoShield vaccine on May 23, 2022. Participants include healthy people ages 18 through 55 years old, and assigned to different study groups based on …
VASA International Stakeholder Meeting in Ouagadougou
The Vaccines Against Schistosomiasis for Africa (VASA) consortium and the International Institute of Science and Technology (IIS Tech) co-hosted the first International Symposium on Tropical Diseases on November 24-26, 2022 in Ouagadougou Burkina Faso. The theme of this meeting was "Technological …
VASA International Stakeholder Meeting in OuagadougouRead More
VASA General Assembly Meeting
Vaccine Against Schistosomiasis for Africa (VASA) project consortium held an annual General Assembly Meeting on 27 January 2022. On a yearly basis, members from the VASA project consortium are gathered to exchange the achievements and current status of ongoing Work Packages including the clinical …
Burkina Faso site pre-assessment visit
UCAM-IVI 1st pre-site assessment visit in Ouagadougou, Burkina Faso was conducted on 26-29 November 2019. During the visit, a group of members from the University of Cambridge and International Vaccine Institute visited the Groupe de Recherche Action en Santé (GRAS) and University of Ouagadougou for …